Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000899243-20-004410)

Filing Details

Accession Number:: 0000899243-20-004410
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2020-02-12 21:27:59
Reporting Period:: 2019-11-25

Accepted Time:: 2020-02-12 21:27:59
Original Submission Date:: 2019-11-26
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1615219	Salarius Pharmaceuticals Inc.	SLRX	()	4/A

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1233253	C Arnold Hanish	C/O Salarius Pharmaceuticals, Inc. 2450 Holcombe Blvd., Suite J - 608 Houston TX 77021		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-11-25	3,000	$3.59	3,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

This Form 4/A is being filed to amend the Form 4 filed by the Reporting Person on November 26, 2019 to correct the amount of securities beneficially owned following the reported transaction under Box 5 of Table I as reflected herein.